Intellectual Property & Patents
Latest News

Advertisement
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
T-Therapeutics Raises $133 Million to Take TCR Bispecifics Into the Clinic
2
The BioPharm Brief: Ivonescimab Priority Review in China, Stargardt Gene Therapy Moves Toward Phase 3, and Longer Dosing Intervals for an IBD Bispecific
3
Boehringer Ingelheim Licenses Six Preclinical ADC and T-Cell Engager Programs From SBP Group in Deal Worth Up to $7 Billion
4
China Grants Ivonescimab Priority Review in Biliary Tract Cancer
5